在PNPO缺乏症中肝移植:管理挑战和生物学教训
Richard Webster1, Bindu Parayil Sankaran1,2, Sushil Bandodkar3
1T.Y. Nelson Department of Neurology and Neurosurgery Children's Hospital at Westmead Sydney Australia.
JIMD reports
|January 13, 2026
概括
皮里多克素胺5′酸氧化酶缺乏症 (PNPO) 即使在肝移植后也需要高剂量的皮里多克素5′酸盐 (PLP). 神经元中受损的PLP救援,而不是肝功能,决定了持续的超生理学PLP需求.
科学领域:
- 生物化学 生物化学
- 神经学 神经学
- 移植 移植 移植 移植
背景情况:
- 皮里多克斯胺5'酸氧化酶缺乏症 (PNPO) 导致耐火性,可用维生素B6形式治疗.
- 一名患有PNPO缺乏和肝硬化的15岁男孩因肝细胞癌而接受肝移植.
研究的目的:
- 在肝移植后的PNPO患者中,监测和管理维生素B6的维生素,特别是氧化5′ (PLP).
- 调查肝移植对PLP需求的影响,并确定导致脑病变的因素.
主要方法:
- 在移植前和移植后进行持续的EEG监测以检测脑病变.
- 在脑病发作期间和药理动力学方面对B6维生素 (PN,PM,PL,PNP,PMP,PLP) 的测定.
- 静脉注射 (IV) 和口服PLP剂量的定位,以平衡疗效和毒性.
主要成果:
- 脑病变发生在低血PL和高PLP水平,表明神经元救援问题.
- PLP表现出剂量依赖的肝毒性,需要仔细调整剂量.
- 移植后过渡到口服PLP具有挑战性,需要在9个月内逐渐增加和频繁剂量.
- 移植后六年,观察到中度门纤维化,持续的超生理学PLP需求.
结论:
- 肝移植并没有消除在PNPO缺乏症中需要超生理学PLP剂量的需要.
- 损伤神经元的PLP救援是PNPO患者PLP需求的主要决定因素.
- 谨慎的PLP剂量定位和频繁的服用对于管理脑病变和最大限度地降低肝毒性至关重要.
相关概念视频
Kidney Transplant I: Introduction
333
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
333
Kidney Transplant III: Nursing Management
307
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
307
Tissue Transplantation
888
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
888
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
179
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
179
Kidney Transplant II: Surgical Procedure
298
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
298
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
210
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
210


